|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$18,492
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
$736,650
|
Custer, Mary
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$645,827
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,144,166
|
$643,250
|
Edelman, Daniel
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,804,021
|
$1,443,217
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,790,549
|
$716,220
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,579,134
|
$157,913
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,469,022
|
$146,902
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,224,110
|
$61,206
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,030,869
|
$773,152
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,030,869
|
$1,020,561
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,022,402
|
$102,240
|
Young, Howard
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$71,045
|
Barr, Frederic
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$971,265
|
$48,563
|
Gottesman, Michael
|
CCR (NCI)
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$897,428
|
$628,199
|
Westlake, Christopher
|
CCR (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$854,010
|
$85,401
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$852,962
|
$341,185
|
Hou, Steven
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$39,573
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$773,152
|
$502,549
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$729,417
|
$218,825
|
Yang, James
|
CCR (NCI)
|
|
Growth-Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$673,059
|
$605,753
|
Perantoni, Alan
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$637,800
|
$127,560
|
Meier, Jordan
|
CCR (NCI)
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$596,457
|
$89,469
|
Trepel, Jane
|
CCR (NCI)
|
|
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
|
ZIA SC 010074
|
$540,890
|
$216,356
|
Neckers, Leonard
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$539,065
|
$539,065
|
Apolo, Andrea
|
CCR (NCI)
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$538,087
|
$538,087
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,915
|
$26,346
|
Khan, Javed
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,435
|
$386,576
|
Linehan, W. Marston
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$515,260
|
$51,526
|
Garfield, Susan
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$485,441
|
$485,441
|
Barchi, Joseph
|
CCR (NCI)
|
|
Genetics of Complex Diseases and Health Disparities
|
ZIA BC 010022
|
$475,508
|
$475,508
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
|
ZIA BC 011648
|
$468,705
|
$468,705
|
Srinivasan, Ramaprasad
|
CCR (NCI)
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$444,333
|
$266,600
|
Vocke, Cathy
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$438,983
|
$43,898
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$380,475
|
$190,237
|
Pinto, Peter
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
$22,414
|
Gottesman, Michael
|
CCR (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$372,064
|
$186,032
|
Citrin, Deborah
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$371,569
|
$185,785
|
Bottaro, Donald
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$368,356
|
$18,418
|
Jones, Jennifer
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$364,996
|
$182,498
|
Buck, Christopher
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$364,996
|
$255,497
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$359,376
|
$359,376
|
Apolo, Andrea
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$7,069
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$345,321
|
$34,532
|
Figg, William
|
CCR (NCI)
|
|
Promoting tumor cell apoptosis by death ligands
|
ZIA BC 011056
|
$324,344
|
$97,303
|
Sayers, Thomas
|
CCR (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$317,006
|
$126,802
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$280,052
|
$84,015
|
Beutler, John
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$276,836
|
$27,684
|
Mackem, Susan
|
CCR (NCI)
|
|
Role of FH loss in development of HLRCC heriditary kidney cancer
|
ZIA BC 010683
|
$270,445
|
$270,445
|
Neckers, Leonard
|
CCR (NCI)
|
|
Translational Physician-Scientist Training Program in Oncology
|
4T32CA160040-04
|
$252,582
|
$63,146
|
SHIN, DONG
|
EMORY UNIVERSITY
|
Total relevant funding to Urinary System for this search: $16,734,874
|